12:34:01 EDT Fri 30 Sep 2022
Enter Symbol
or Name

Login ID:
Canaccord Genuity Group Inc
Symbol CF
Shares Issued 108,477,450
Close 2019-08-14 C$ 5.08
Recent Sedar Documents

SEC fines Canaccord $250,000 (U.S.) for OTC violations

2019-08-14 18:15 ET - Street Wire

See Street Wire (U-*SEC) U S Securities and Exchange Commission

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

The U.S. Securities and Exchange Commission has fined Canaccord Genuity LLC $250,000 for failures related to its work in over-the-counter stocks. (All figures are in U.S. dollars.) The SEC says that the firm was a market-maker for dozens of thinly traded OTC securities, but did not ensure that the disclosure of the issuers was accurate. Among other things, Canaccord was supposed to review the prospectuses and financial statements of the companies.

The penalty for Canaccord is contained in an order instituting proceedings that the SEC released on Wednesday, Aug. 14. In addition to the $250,000 fine, the SEC has imposed an order barring any future violations by Canaccord. The sanctions represent a negotiated settlement, in which Canaccord did not admit any wrongdoing.

The SEC's case centres around the reporting for OTC and non-listed securities for which Canaccord was making a market. In the U.S., brokerages are required to maintain information about such issuers, including financial statements. Brokerages must review the material and have a reasonable basis to believe that the information is accurate. A designated person must sign a document, known as Form 211, validating that the material is accurate and that it came from a reliable source.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2022 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.

Comments for this item are closed